We are thrilled to share Jesse Selber, M.D., MPH, MHCM, will join Corewell Health East in January as our Surgery Service Line chief and as a professor of Plastic Surgery. Dr. Selber currently serves as vice chair, director of Clinical Research and professor in the Department of Plastic Surgery at the University of Texas MD Anderson Cancer Center in Houston.

Board certified in Plastic Surgery, he is an expert in microvascular reconstructive surgery. Dr. Selber pioneered the field of robotic plastic surgery and remains the leading researcher and practitioner in robotic plastic surgery.

After earning his Medical Doctorate from the University of Rochester School of Medicine and Dentistry, Dr. Selber completed a Master of Public Health at Harvard followed by a Plastic Surgery residency at the University of Pennsylvania. In 2009, he completed a fellowship in Microvascular Reconstructive Surgery at MD Anderson Cancer Center. In 2020, he earned a Master of Health Care Management from Harvard.

Dr. Selber’s clinical practice has been exclusively complex cancer reconstruction. He is a surgical innovator, developing numerous techniques, including all existing robotic applications in plastic surgery and the only robotic plastic surgery textbook. He has authored more than 150 peer-reviewed publications and numerous book chapters; given more than 350 national and international presentations; serves on three editorial boards; and is an editor for seven peer-reviewed journals.

Administratively, Dr. Selber has been instrumental in developing and implementing the MD Anderson Cancer Network, extending world class cancer care around the Nation and the World. His administrative interests are Operations Management, Behavioral Economics, Health Systems, Organizational Behavior and Strategy.

Dr. Selber is eager to move to Michigan and work with our phenomenal team. He looks forward to exploring the opportunities and welcomes your input as he shapes this important program. We are confident Dr. Selber will strengthen the surgery service line and our clinical research programs.